BioUtah Opens Early Registration for 2025 Life Sciences Summit

BioUtah, Utah's premier life sciences trade association, has officially opened Early Bird registration for the highly anticipated 2025 Utah Life Sciences Summit, presented in partnership with Mayer Brown. The flagship event, scheduled for November 12 at the Hilton Salt Lake City Center, offers reduced pricing through October 17, making this the perfect opportunity for professionals to secure their spot at a discounted rate. Attendees can register HERE to take advantage of these early bird savings and view the preliminary agenda HERE to plan their summit experience. This premier gathering consistently attracts over 500 registrants, bringing together top life sciences leaders, experts, policymakers, and professionals for a day focused on industry dynamics, regulatory landscapes, market trends, and innovation strategies.

The summit features an impressive roster of keynote speakers who will address critical issues affecting Utah's thriving life sciences ecosystem. Melissa Holyoak, Commissioner of the Federal Trade Commission and a Utah native, brings her expertise in consumer protection and healthcare market competition. Michelle Tarver, MD, PhD, Director of FDA's Center for Devices and Radiological Health, will conduct a virtual FDA Town Hall to discuss policy priorities and regulatory initiatives. Peter Marks, MD, the former head of FDA's Center for Biologics Evaluation and Research, shares his experience overseeing the rapid expansion of cell and gene therapies and his key role in Operation Warp Speed. Carter Dredge, Executive Director of the Intermountain Health Institute, rounds out the lineup as a global healthcare thought leader focused on creating novel solutions to complex challenges.

Beyond the educational sessions, the Utah Life Sciences Summit offers dedicated networking opportunities, including a lunchtime program designed to facilitate meaningful professional connections. The event will feature specialized tracks covering workforce development, market access, regulatory and quality issues, and legal considerations. BioUtah will also present awards recognizing outstanding contributions and achievements within the life sciences sector. As Kelvyn Cullimore, president and CEO of BioUtah, emphasizes, the summit brings together everyone from groundbreaking startups to established industry leaders for discovery, collaboration, and inspiration. Utah's life sciences industry has emerged as a national powerhouse, contributing $22.6 billion to the state's GDP and supporting approximately 180,000 jobs, making this summit essential for anyone involved in medical device manufacturing, diagnostics, biopharmaceuticals, or related fields.